Ginkgo bioworks announces participation in the 44th annual td cowen health care conference

Boston , feb. 27, 2024 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced that co-founder and ceo, jason kelly, is scheduled to participate in cowen's 44th annual health care conference on tuesday, march 5, 2024 at 2:10 p.m. et. the presentation details and webcast link will be available on ginkgo's investor relations website at https://investors.ginkgobioworks.com , and a replay will be made available.
DNA Ratings Summary
DNA Quant Ranking